RIPK1 and neoplasm: However, the inhibition of RIPK1 in a mouse model of pancreatic ductal adenocarcinoma, however, did not result in an improvement in overall survival or tumor growth.265 Noteworthy, there may be differences in immunogenicity between the two groups based on the differences in pancreatic mouse models.